Archive for June, 2010

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial

Adjuvant Aspirin Therapy Reduces Symptoms of Schizophrenia Spectrum Disorders: Results From a Randomized, Double-Blind, Placebo-Controlled Trial

Posted on03. Jun, 2010 by .

0

Wijnand Laan, PhD; Diederick E. Grobbee, MD, PhD; Jean-Paul Selten, MD, PhD; Cobi J. Heijnen, PhD; René S. Kahn, MD, PhD; and Huibert Burger, MD, PhD  http://article.psychiatrist.com/dao_1-login.asp?ID=10006874&RSID=40173234257663  J Clin Psychiatry 2010;71(5):520–527 10.4088/JCP.09m05117yel  © Copyright 2010 Physicians Postgraduate Press, Inc.  Objective: Inflammatory processes may play a role in the pathophysiology of schizophrenia. The aim of this […]

Continue Reading

Thinking Outside a Less Intact Box

Thinking Outside a Less Intact Box

Posted on01. Jun, 2010 by .

0

Thalamic Dopamine D2 Receptor Densities Are Negatively Related to Psychometric Creativity in Healthy Individuals Several lines of evidence support that dopaminergic neurotransmission plays a role in creative thought and behavior. Here, we investigated the relationship between creative ability and dopamine D2 receptor expression in healthy individuals, with a focus on regions where aberrations in dopaminergic […]

Continue Reading